Turning Point Brands shares jumped 15% after the quarter, driven primarily by outsized growth in the Modern Oral segment, which more than doubled sales year-over-year and expanded retail distribution faster than expected.

• Modern Oral gross and net sales increased 167% and 133% year-over-year, contributing 42% of total revenue, up from 21% a year ago.
• Growth was driven by both direct-to-consumer strength and accelerated expansion into larger chain convenience stores, with chain store count expected to increase 70% year-over-year by end of 2026.
• Company is investing heavily in sales force, marketing, and manufacturing capacity (including commissioning a Louisville facility), expecting these to support margin expansion toward a long-term 70% target.
• First-quarter investments in marketing partnerships and brand building aim to increase consumer awareness and support future retail productivity gains.
• Management framed results as early innings of a generational shift in nicotine consumption, reinforcing confidence in long-term category share goals.